Liby KT - Search Results

1

A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice.

Zhang D, Baldwin P, Leal AS, Carapellucci S, Sridhar S, Liby KT. Zhang D, et al. Among authors: liby kt. Theranostics. 2019 Aug 14;9(21):6224-6238. doi: 10.7150/thno.36281. eCollection 2019. Theranostics. 2019. PMID: 31534547 Free PMC article.

2

The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.

Leal AS, Sporn MB, Pioli PA, Liby KT. Leal AS, et al. Among authors: liby kt. Carcinogenesis. 2016 Dec;37(12):1170-1179. doi: 10.1093/carcin/bgw099. Epub 2016 Sep 22. Carcinogenesis. 2016. PMID: 27659181 Free PMC article.

3

Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.

Leal AS, Williams CR, Royce DB, Pioli PA, Sporn MB, Liby KT. Leal AS, et al. Among authors: liby kt. Cancer Lett. 2017 May 28;394:76-87. doi: 10.1016/j.canlet.2017.02.021. Epub 2017 Feb 27. Cancer Lett. 2017. PMID: 28254412

4

Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-deficient Breast Cancer.

Belz JE, Kumar R, Baldwin P, Ojo NC, Leal AS, Royce DB, Zhang D, van de Ven AL, Liby KT, Sridhar S. Belz JE, et al. Among authors: liby kt. Theranostics. 2017 Sep 26;7(17):4340-4349. doi: 10.7150/thno.18563. eCollection 2017. Theranostics. 2017. PMID: 29158830 Free PMC article.

5

A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation.

Chakraborty D, Benham V, Jdanov V, Bullard B, Leal AS, Liby KT, Bernard JJ. Chakraborty D, et al. Among authors: liby kt. Cancer Prev Res (Phila). 2018 Mar;11(3):129-142. doi: 10.1158/1940-6207.CAPR-17-0262. Epub 2017 Dec 15. Cancer Prev Res (Phila). 2018. PMID: 29246955

6

Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762.

Zhang D, Leal AS, Carapellucci S, Zydeck K, Sporn MB, Liby KT. Zhang D, et al. Among authors: liby kt. Cancer Prev Res (Phila). 2018 Mar;11(3):143-156. doi: 10.1158/1940-6207.CAPR-17-0264. Epub 2017 Dec 15. Cancer Prev Res (Phila). 2018. PMID: 29246957 Free PMC article.

7

Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice.

Zhang D, Rennhack J, Andrechek ER, Rockwell CE, Liby KT. Zhang D, et al. Among authors: liby kt. Antioxid Redox Signal. 2018 Dec 1;29(16):1535-1552. doi: 10.1089/ars.2017.7201. Epub 2018 Apr 16. Antioxid Redox Signal. 2018. PMID: 29634345 Free PMC article.

8

Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer.

Leal AS, Liby KT. Leal AS, et al. Among authors: liby kt. Curr Protoc Pharmacol. 2018 Dec;83(1):e48. doi: 10.1002/cpph.48. Epub 2018 Oct 16. Curr Protoc Pharmacol. 2018. PMID: 30325112

9

Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1.

Kolsi LE, Leal AS, Yli-Kauhaluoma J, Liby KT, Moreira VM. Kolsi LE, et al. Among authors: liby kt. Sci Rep. 2018 Oct 29;8(1):15923. doi: 10.1038/s41598-018-34131-1. Sci Rep. 2018. PMID: 30374056 Free PMC article.

10

Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention.

Zhang D, Leal AS, Carapellucci S, Shahani PH, Bhogal JS, Ibrahim S, Raban S, Jurutka PW, Marshall PA, Sporn MB, Wagner CE, Liby KT. Zhang D, et al. Among authors: liby kt. Cancer Prev Res (Phila). 2019 Apr;12(4):211-224. doi: 10.1158/1940-6207.CAPR-18-0317. Epub 2019 Feb 13. Cancer Prev Res (Phila). 2019. PMID: 30760500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters